Treating Patients with NSCLC: Decision-Making and Surgical Considerations

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ravi Rajaram, MD, MSC NEOSTAR is a phase 2 trial with multiple arms looking at different combination therapies in the setting of resectable lung cancer. So what results were found from this study? Join in as Dr. Charles Turck discusses this further with Dr. Ravi Rajaram, Assistant Professor and the Clinical Medical Director in the Thoracic Center in the Department of Thoracic and Cardiovascular Surgery, Division of Surgery, at the University of Texas MD Anderson Cancer Center in Houston.